Morphea
☆ AI Dermatology — Free Service
I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
Ko te nuinga o te wā ka puta he papawai atrophic i te mate o Morphea.
relevance score : -100.0%
ReferencesKo te scleroderma he mate onge e pā ana ki ngā kopa honohono, ka kitea he kiri whakapakeke, ā, i ētahi wā ka pā ki ētahi atu wāhanga o te tinana. E rua ngā momo matua: systemic sclerosis, e pā ana ki te whakapakeke o te kiri me ngā whekau o roto, me te localized scleroderma, e kīia ana ko te morphea, ka noho iti ki te kiri me ngā kopa kei raro iho, me te akoranga ngawari me te whakaiti i a ia anō. Ahakoa he tauhou te scleroderma o te rohe me te kore e mārama ana te take, ko ngā rangahau o nāianei e kī ana ka pā ki ngā whekau o roto, ka pā atu ki ngā momo take hauora. He mea tino nui te maimoatanga mō te aukati i ngā raruraru, i te mea ko te taumahatanga pea o te localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Ko te Morphea, e mohiotia ana ko te scleroderma rohe, he mate autoimmune e pā ana ki te kiko hono. Ka puta mai i roto i ngā huarahi rerekē, ā, ehara i te mea tino noa, me te āhua 0.4–2.7 mō ia 100,000 tāngata i ia tau. Ka kitea te Morphea i ngā tamariki kei waenga i te 2 ki te 14 tau, ā, he maha ake te pā ki ngā kotiro i ngā tama.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Ko Morphea he mate ongo. Nā te hanganga o te whakaahua, i pohehe pea te algorithm mō te Morphea.